We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-3.26%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.67B
AUM Growth
+$134M
Cap. Flow
+$180M
Cap. Flow %
10.83%
Top 10 Hldgs %
42.41%
Holding
98
New
25
Increased
27
Reduced
17
Closed
21

Sector Composition

Rank Sector Weight
1 Healthcare 37.02%
2 Consumer Discretionary 19.39%
3 Consumer Staples 7.59%
4 Industrials 2.26%
5 Communication Services 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTNP
76
DELISTED
Titan Pharmaceuticals
TTNP
$46K ﹤0.01%
+61
New +$166K
ACHV icon
77
Achieve Life Sciences
ACHV
$659M
-3,100
Closed -$234K
AMZN icon
78
Amazon
AMZN
$2.92T
-40,000
Closed -$3.4M
ATXS
79
DELISTED
Astria Therapeutics
ATXS
-33,333
Closed -$1.92M
BGS icon
80
B&G Foods
BGS
$287M
-700,000
Closed -$20.9M
CRSP icon
81
CRISPR Therapeutics
CRSP
$4.73B
-124,000
Closed -$7.29M
DBI icon
82
Designer Brands
DBI
$307M
-280,000
Closed -$7.23M
EPC icon
83
CALL
Edgewell Personal Care
EPC
$1.25B
-350,000
Closed -$17.7M
FRPT icon
84
CALL
Freshpet
FRPT
$2.93B
-1,000,000
Closed -$27.4M
INCY icon
85
Incyte
INCY
$24.2B
-428,000
Closed -$29.4M
PZZA icon
86
CALL
Papa John's
PZZA
$984M
-750,000
Closed -$38M
PZZA icon
87
Papa John's
PZZA
$984M
-250,000
Closed -$12.7M
SMPL icon
88
Simply Good Foods
SMPL
$901M
-1,460,000
Closed -$21.1M
TBPH icon
89
Theravance Biopharma
TBPH
$874M
-1,180,000
Closed -$26.8M
YELP icon
90
Yelp
YELP
$1.45B
-200,000
Closed -$7.84M
PRKS icon
91
United Parks & Resorts
PRKS
$2.1B
-1,576,000
Closed -$34.4M
APRN
92
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
-22,222
Closed -$9.73M
NOVN
93
DELISTED
Novan, Inc. Common Stock
NOVN
-50,000
Closed -$1.47M
ALXN
94
DELISTED
Alexion Pharmaceuticals
ALXN
-112,000
Closed -$13.9M
ZOES
95
DELISTED
Zoe's Kitchen, Inc.
ZOES
-593,321
Closed -$5.79M
STDY
96
DELISTED
SteadyMed Ltd
STDY
-497,044
Closed -$2.24M
CELG
97
DELISTED
Celgene Corp
CELG
-175,000
Closed -$13.9M

Similar funds

Armistice Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Armistice Capital held 98 positions worth $1.67B, up 8.8% from $1.53B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Armistice Capital deployed $180M of net new capital in Q3 2018, opening 25 new positions and adding to 27 existing holdings. Its largest new stake was United Therapeutics: 292,000 shares worth $37.3M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Somnigroup International, an estimated $40.4M trimmed.

  • Armistice Capital's largest Q3 2018 buy was United Therapeutics: 292,000 shares worth $37.3M.
  • Armistice Capital added most to Clovis Oncology, Inc. in Q3 2018, an estimated $39.2M increase.
  • Armistice Capital's biggest Q3 2018 reduction was Somnigroup International, cutting an estimated $40.4M.
  • Armistice Capital fully exited United Parks & Resorts in Q3 2018, selling an estimated $34.4M.
  • Armistice Capital's ten largest holdings make up 42% of its $1.67B portfolio in Q3 2018.
  • Armistice Capital opened 25 new positions and closed 21 in Q3 2018.
  • Armistice Capital's portfolio value rose 8.8% quarter-over-quarter to $1.67B.

Based on Armistice Capital's 13F filing for Q3 2018, filed 14 Nov 2018.